Reaction kettle, system and method for carrying out tissue decellularization on supercritical carbon dioxide fluid based on hydrodynamic vortex self-acting effect

By introducing a porous scaffold and an arc-shaped vortex generator into a supercritical carbon dioxide reactor to form a vortex, combined with an internal and external circulation system, the problem of balancing decellularization efficiency and matrix integrity in existing technologies has been solved, achieving a highly efficient, uniform, scalable, and environmentally friendly decellularization effect.

CN121360522APending Publication Date: 2026-01-20FUJIAN INST OF RES ON THE STRUCTURE OF MATTER CHINESE ACAD OF SCI
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202511347339.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-09-19
Publication Date
2026-01-20

AI Technical Summary

Technical Problem

Existing supercritical carbon dioxide (scCO2) decellularization technology suffers from the problem of balancing decellularization efficiency with matrix integrity. Static immersion is inefficient, while high-speed perfusion or mechanical stirring can damage the ECM structure. Furthermore, it lacks external circulation and purification design, making it difficult to meet the needs of large-scale production.

Method used

The reactor design adopts the self-generating effect of eddy currents in fluid dynamics. It utilizes a porous tissue scaffold and an arc-shaped vortex booster to form eddies. Combined with internal and external circulation systems, it achieves uniform flushing and reuse of supercritical carbon dioxide fluid, avoiding high shear force damage caused by mechanical stirring.

Benefits of technology

It improves the efficiency and thoroughness of decellularization, protects the natural structure and bioactivity of ECM, reduces operating costs and equipment complexity, and achieves a highly efficient, uniform, scalable, and environmentally friendly decellularization process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121360522A_ABST
    Figure CN121360522A_ABST
Patent Text Reader

Abstract

The invention discloses a supercritical carbon dioxide fluid tissue decellularization reaction kettle, system and method based on hydrodynamic eddy current self-generating effect, the reaction kettle comprises a kettle cover, a hoop and a pressure-bearing kettle body, and the pressure-bearing kettle body and the kettle cover are fixed through the hoop; a porous tissue support comprising a top porous plate and a bottom porous plate is arranged in the reaction kettle, an internal space is formed after the bottom and the top porous plate are fixed, the vortex assisting device and the tissue cage are detachably fixed in the internal space, and the tissue cage is arranged below the top porous plate and above the vortex assisting device; the supercritical carbon dioxide fluid enters the reaction kettle to impact the vortex-assisting device, and the vortex-assisting device guides the supercritical carbon dioxide fluid upwards and forms a local recirculation vortex in the tissue cage. The supercritical carbon dioxide fluid is used as a treatment medium, the decellularization efficiency and quality are improved by optimizing fluid dynamics in the reaction kettle and integrating system circulation, and the efficient, uniform, large-scale, low-cost and environment-friendly decellularization process is realized.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present application relates to the technical field of biomedical engineering and tissue engineering, and relates to a reactor device for biological tissue decellularization and a method for using the same, in particular to a reactor based on the self-generating effect of fluid dynamics vortex for tissue decellularization by supercritical carbon dioxide fluid. BACKGROUND

[0002] One of the core purposes of tissue engineering and regenerative medicine is to repair or replace damaged tissues and organs to restore their normal physiological functions. Tissue engineering research focuses on the use of three main components: cells, signaling molecules and scaffolds. Scaffolds provide structural and mechanical support for cells with signaling molecules. They can be made of synthetic materials and natural materials. Synthetic scaffolds can be prepared according to the specific requirements of the tissue to obtain the required scaffolds with chemical and mechanical properties. However, the current synthetic scaffolds have corresponding defects in terms of biocompatibility, degradation rate and simulation of complex microenvironment. Therefore, researchers have been trying to prepare scaffolds of natural origin to obtain scaffolds with excellent biocompatibility and biological activity.

[0003] Tissues and organs are composed of cells and extracellular matrix (ECM), which is a product secreted by cells in the tissue to maintain structure and function. The structure of ECM is different due to specific factors such as mechanical force, biochemical environment of the tissue, and plays an important role in cell activities such as cell migration, proliferation and three-dimensional organization of tissues. Because of its excellent function, scaffolds that mimic the structure of ECM and tissues are one of the current popular research topics and a promising method for tissue engineering research.

[0004] In this frontier field, decellularized extracellular matrix (dECM) is playing an increasingly critical role as an ideal natural biological scaffold material. In tissue engineering and regenerative medicine applications, decellularized tissues have been widely used to manufacture ideal tissue replacement scaffolds, such as nerves, blood vessels, tendons, livers, etc. The purpose of the decellularization process is to effectively remove cells and nucleic acid components to eliminate immune rejection reactions, while maximizing the preservation of the intact structure of ECM, such as collagen, glycosaminoglycans (GAGs), growth factors, and mechanical properties. This natural dECM scaffold can provide an excellent biomimetic microenvironment for the adhesion, proliferation, and directional differentiation of seed cells, guiding tissue regeneration. The application of dECM is very extensive now, especially in the field of biological 3D printing. High-quality dECM is the core raw material for preparing functional biological ink. Through the strategy of 3D printing, the original tissue and organ microenvironment can be replicated to construct in vitro tissue models or transplantable tissue structures with physiological functions.

[0005] However, there are some difficulties in achieving the ideal decellularization effect. In the decellularization process, the intensity of the treatment must be sufficient to lyse the cell membrane, dissolve the cell contents, and remove them from the dense ECM lattice, but this will have a certain negative impact on the fine ECM structure and composition. Mild decellularization techniques are more effective in preserving ECM components, but may be less effective in eliminating unwanted cells.

[0006] Current decellularization methods are mainly divided into chemical, biological, and physical methods. Traditional chemical methods, especially the use of strong ionic detergents such as sodium dodecyl sulfate (SDS), although efficient in removing cells, have a rough mechanism of action. Studies have shown that SDS can severely damage the structural integrity of ECM, often leading to denaturation of key proteins in ECM, massive loss of GAGs, and possibly leaving chemical residues with cytotoxicity in the scaffold. Removing these chemical residues requires a large number of time-consuming washing steps to remove, and the washing process itself can also cause secondary damage to the scaffold. In contrast, although non-ionic detergents such as Triton X-100 are relatively mild, their decellularization efficiency is often low, making it difficult to meet the requirements of clinical applications.

[0007] Biological methods, i.e., enzymatic decellularization, have certain specificity, but are difficult to control accurately, may degrade target ECM components, and are costly. Physical methods, such as repeated freeze-thawing, have less damage to the matrix structure, but have low cell removal efficiency, especially in removing DNA and other immunogenic substances, and their application is greatly limited. Therefore, the existing technology generally has low efficiency, incomplete retention of ECM components, and long processing period, making it difficult to achieve efficient, mild, and safe dECM preparation.

[0008] To overcome the drawbacks of traditional methods, supercritical carbon dioxide (scCO2) technology emerges as an innovative decellularization solution. When the temperature and pressure exceed its critical point (T c = 31.1℃,

[0009] P c = 7.38Mpa), CO2 forms a special fluid phase, combining the low viscosity and high diffusivity of gas with the density and solubility of liquid. scCO2 has the advantages of non-toxicity, no residue, and mild operating conditions, and is considered a highly potential green decellularization technology.

[0010] However, a search and analysis of the existing technology shows that the current scCO2 decellularization technology still has some core defects, mainly due to the deficiencies in the design of the reactor system, leading to a difficult-to-reconcile technical contradiction between decellularization efficiency and matrix integrity.

[0011] Most of the existing disclosed devices use static soaking or simple one-way fluid flushing. For example, Chinese patent CN119156236A and Japanese patent JP2007105081A describe soaking the tissue in scCO2 or its mixture with a cosolvent for treatment. Although this method avoids mechanical damage to the ECM, it has a serious mass transfer limitation problem. The scCO2 fluid is difficult to uniformly penetrate into the tissue, and during the treatment process, the fluid only flows along the path with the smallest resistance, i.e., the so-called "channeling effect", which leads to uneven and incomplete decellularization of the core area of the tissue, and low overall treatment efficiency.

[0012] To solve the problem of low mass transfer efficiency, some solutions attempt to use high-speed perfusion. However, too high a flow rate will cause irreversible high shear stress damage to the fine structure of the ECM. For example, studies have shown that a perfusion flow rate of 400mL / min will cause obvious physical tearing and structural damage to the inner wall of the blood vessels, which seriously affects the mechanical properties and biological functions of the final scaffold.

[0013] Another idea is to introduce mechanical stirring to enhance mass transfer. For example, Chinese patents CN1445003A and CN114591832A respectively use a motor-driven rotating cage and a rotating box. This active stirring device not only significantly increases the design, manufacturing cost and sealing difficulty of the high-pressure reactor, but also the rotation of the stirring paddle generates uncontrollable shear force, causing physical damage to the fragile ECM structure, and is prone to produce processing "dead angle", and the uniformity is still difficult to guarantee.

[0014] In addition, the existing scCO2 system also generally lacks closed-loop design of external circulation, purification and reuse, which not only limits the amount of tissue processed at a time and cannot meet the demand of large-scale production, but also directly discharges a large amount of CO2, which is neither economical nor environmentally friendly.

[0015] In summary, the existing scCO2 decellularization technology is in a dilemma: the forced convection or mechanical stirring method for high efficiency will sacrifice the integrity of the matrix, while the static method to protect the integrity of the matrix is inefficient. Therefore, there is an urgent need in the art to develop a new technical solution that can optimize the internal structure of the reactor and the fluid organization method without introducing mechanical stirring, to strengthen the dynamic flushing of the fluid to the tissue, and combine with the external circulation of the fluid, to solve the pain points of the existing technology, and realize an efficient, uniform, controllable, scalable and green and environmentally friendly tissue decellularization process. SUMMARY

[0016] To solve the above problems, the present application provides a reaction kettle, system and method for tissue decellularization based on the fluid dynamics vortex self-generation effect of supercritical carbon dioxide fluid, aiming to solve the technical contradiction that high efficiency and ECM structure integrity are difficult to be balanced in the existing scCO2 decellularization technology, and to realize an efficient, uniform, scalable, low-cost and green and environmentally friendly decellularization process.

[0017] To achieve the above purpose, the present application provides the following technical solutions:

[0018] The present application provides a reaction kettle for tissue decellularization based on the fluid dynamics vortex self-generation effect of supercritical carbon dioxide fluid, the reaction kettle comprising a kettle cover, a clamp and a pressure-bearing kettle body, the pressure-bearing kettle body being fixed with the kettle cover through the clamp;

[0019] A porous tissue scaffold is arranged in the reaction kettle, the porous tissue scaffold comprising a top porous plate and a bottom porous plate with a circumferential side wall, the bottom porous plate and the top porous plate forming an internal space after being fixed, a vortex inducer and a tissue cage being detachably fixed in the internal space of the porous tissue scaffold, the tissue cage being arranged below the top porous plate and above the vortex inducer;

[0020] The supercritical carbon dioxide fluid enters the reactor and impacts the vortex inducer, which guides the supercritical carbon dioxide fluid upward and forms a local recirculation vortex in the tissue cage.

[0021] In an alternative embodiment, the top porous plate and the bottom porous plate are respectively arranged with a plurality of holes, and the hole diameter of the holes on the bottom porous plate is larger than the hole diameter of the holes on the top porous plate.

[0022] In an alternative embodiment, the pressure vessel is respectively provided with a fluid inlet and a fluid outlet, the fluid inlet is arranged at the center of the bottom of the pressure vessel, and the fluid outlet is arranged on the upper portion of the side wall of the pressure vessel.

[0023] In an alternative embodiment, the vortex inducer includes an impact surface, a leg, and a support, the impact surface is arranged above the fluid inlet, the impact surface is fixed at the center of the support through the leg, and the vortex inducer is detachably fixed to the side wall of the bottom porous plate through the support.

[0024] In an alternative embodiment, the impact surface is a crescent-shaped arc structure.

[0025] In an alternative embodiment, the upper and lower surfaces and the peripheral surface of the tissue cage are respectively arranged with a plurality of holes, a plurality of mounting lugs are equidistantly arranged on the upper edge of the peripheral surface of the tissue cage, the lower surface of the top porous plate is provided with a connecting sleeve corresponding to the mounting lug, and the tissue cage is detachably fixed to the top porous plate through the threaded connection of the mounting lug and the connecting sleeve.

[0026] In an alternative embodiment, the pressure vessel is also provided with a cosolvent adding inlet.

[0027] The application also provides a system for decellularizing tissue based on the vortex self-generation effect of fluid dynamics, which comprises the above-mentioned reactor, a carbon dioxide storage tank, a high-pressure pump, a heat exchanger, a separation tank, and a cosolvent storage tank.

[0028] The outlet end of the carbon dioxide storage tank is connected to the fluid inlet of the reactor through a pipeline, sequentially passing through the high-pressure pump and the heat exchanger, and the fluid outlet of the reactor is connected to the inlet end of the carbon dioxide storage tank through a circulation pipeline after being connected to the separation tank.

[0029] The outlet of the cosolvent storage tank is connected to the cosolvent adding inlet of the reactor through a pipeline.

[0030] The application also provides a method for decellularizing tissue based on the vortex self-generation effect of fluid dynamics using the above-mentioned system, which comprises the following steps:

[0031] Placing the biological tissue to be treated into a tissue cage, sealing the reactor;

[0032] After adjusting the carbon dioxide to a supercritical state, driving the supercritical carbon dioxide fluid into the reactor to perform decellularization treatment on the biological tissue to be treated;

[0033] Obtaining the decellularized extracellular matrix of the biological tissue;

[0034] The supercritical carbon dioxide fluid forms a vortex flow repeatedly flushing the biological tissue to be treated in the reactor through the helical flow promoter.

[0035] In an alternative embodiment, the method further comprises:

[0036] During the decellularization treatment, the cosolvent is added to the reactor through the cosolvent storage tank;

[0037] And / or, after the decellularization treatment is completed, the supercritical carbon dioxide fluid containing the biological tissue lysate flows into the separation tank for separation treatment, and the separated carbon dioxide is recycled for use in the system.

[0038] The beneficial effects of the present application are:

[0039] (1) The present application forms a continuous and repeatedly flushing vortex flow around the decellularized tissue through the built-in arc-shaped helical flow promoter and flow field optimization design, effectively overcoming the problems of uneven decellularization and low efficiency caused by "channeling effect" in the prior art, ensuring sufficient and uniform contact between scCO2 fluid and the tissue, and significantly improving the decellularization efficiency and completeness.

[0040] (2) The present application replaces high-shear mechanical stirring with fluid self-driven vortex flow, achieving gentle dynamic flushing, effectively avoiding physical damage to the ECM microstructure caused by mechanical stirring or high-speed perfusion due to high shear force, and maximizing the preservation of the natural ultrastructure, bioactive components and key mechanical properties of the ECM.

[0041] (3) The integrated external circulation system in the present application realizes the separation and reuse of scCO2 fluid, greatly reducing the consumption and emission of CO2, in line with the principles of green chemistry. At the same time, the high-cost and complex mechanical stirring device is eliminated, and the consumption of raw materials is reduced, significantly reducing the operating cost and equipment manufacturing cost of the entire decellularization process.

[0042] (4) The system design of the present application realizes the combination of internal and external circulation, and the process parameters such as temperature, pressure and flow rate of scCO2 fluid are easy to control, so that the fluid can form a vortex flow inside the reactor to achieve internal circulation. The closed-loop external circulation design breaks the single processing capacity, laying a foundation for efficient and repeatable large-scale production of dECM.

[0043] (5) The system is equipped with a solubilizing agent adding inlet and a storage unit, so that the flexible switching of a pure physical method and a physical-chemical combined method can be realized, the optimal decellularization scheme can be selected according to the characteristics of different tissue types, process optimization and comparison research are facilitated, and the system is widely applicable. BRIEF DESCRIPTION OF DRAWINGS

[0044] Figure 1 is a front view of the reaction kettle of the present application.

[0045] Figure 2 is a longitudinal sectional structure schematic diagram of the reaction kettle of the present application.

[0046] Figure 3 is a structure schematic diagram of the tissue cage of the present application.

[0047] Figure 4 is a structure schematic diagram of the vortex promoter of the reaction kettle of the present application.

[0048] Figure 5 is a structure schematic diagram of the tissue scaffold of the reaction kettle of the present application.

[0049] Figure 6 is a flow field distribution diagram of the kettle body obtained by fluid simulation software simulation.

[0050] Figure 7 is a flow field overhead cloud chart of the kettle body obtained by fluid simulation software simulation.

[0051] Figure 8 is a flow field distribution diagram of the kettle body with the top and bottom porous plates having the same hole diameter.

[0052] Figure 9 is a whole process schematic diagram of the decellularization process system of the present application.

[0053] Fig. 10 is a front view of the reaction kettle of the present application. Fig. 11 is a longitudinal sectional structure schematic diagram of the reaction kettle of the present application. Fig. 12 is a structure schematic diagram of the tissue cage of the present application. Fig. 13 is a structure schematic diagram of the vortex promoter of the reaction kettle of the present application. Fig. 14 is a structure schematic diagram of the tissue scaffold of the reaction kettle of the present application. Fig. 15 is a flow field distribution diagram of the kettle body obtained by fluid simulation software simulation. Fig. 16 is a flow field overhead cloud chart of the kettle body obtained by fluid simulation software simulation. Fig. 17 is a flow field distribution diagram of the kettle body with the top and bottom porous plates having the same hole diameter. Fig. 18 is a whole process schematic diagram of the decellularization process system of the present application. DETAILED DESCRIPTION

[0054] In order to make the purposes, technical solutions and advantages of the present application clearer, the technical solutions in the embodiments of the present application will be described clearly and completely below with reference to the drawings in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, rather than all the embodiments. Based on the embodiments in the present application, all other embodiments obtained by those skilled in the art without creative work fall within the scope of protection of the present application.

[0055] Embodiments of the present application, examples of which are shown in the accompanying drawings, wherein the same or similar reference numerals refer to the same or similar elements or elements having the same or similar functions throughout. The terms "first", "second", "third", etc. in the description and claims of the present application and the drawings, if any, are used to distinguish similar objects, and do not necessarily describe a particular order or sequence. It should be understood that the described objects can be interchanged under appropriate circumstances. In addition, the terms "include" and "have" and any variations thereof are intended to cover non-exclusive inclusion. The direction terms mentioned in the present application, such as: up, down, left, right, front, back, inner, outer, side, etc. are only the direction of the drawings. The embodiments described below with reference to the drawings are exemplary and are only used to explain the present application, and cannot be understood as a limitation of the present application. In addition, the present application repeatedly refers to numbers and / or letters in different examples. Such repetition is for the purpose of simplification and clarity, and does not in itself indicate the relationship between the various embodiments and / or arrangements discussed. In addition, the present application provides examples of various specific processes and materials, but those skilled in the art can realize the application of other processes and / or the use of other materials.

[0056] Embodiment 1

[0057] The present embodiment provides a reaction kettle for tissue decellularization based on the hydrodynamic vortex self-generation effect of supercritical carbon dioxide fluid, as shown in Figure 1 The reaction kettle 10 includes a kettle cover 11, a clamp 12 and a pressure-bearing kettle body 13. The design pressure-bearing capacity of the reaction kettle 10 can reach 30 MPa, and the temperature resistance range covers 35-50℃. The material of the pressure-bearing kettle body 13 is a material with high pressure resistance, corrosion resistance and good biocompatibility.

[0058] The pressure-bearing kettle body 13 and the kettle cover 11 are fixed by the clamp 12. The clamp 12 can lock and seal the reaction kettle 10, which can not only ensure the sealing of the kettle body under high pressure, but also facilitate the quick opening and closing of the operator.

[0059] The pressure vessel body 13 is provided with a fluid inlet 131 and a fluid outlet 132. The fluid inlet 131 is located at the bottom center of the pressure vessel body 13, and the fluid outlet 132 is located on the upper part of the side wall of the pressure vessel body 13. The scCO2 fluid moves in the reactor 10 in a bottom-in, top-out flow pattern.

[0060] Furthermore, a cosolvent addition inlet (not shown) is provided on the pressure vessel body 13 for selectively injecting cosolvent directly into the reaction vessel 10 during the decellularization process.

[0061] like Figures 2-5 As shown, a porous tissue scaffold 14, a vortex booster 15, and a tissue cage 16 are disposed inside the reactor 10. The porous tissue scaffold 14 includes a top porous plate 141 and a bottom porous plate 142 with upwardly extending circumferential sidewalls. After the bottom porous plate 142 and the top porous plate 141 are fixed, they form an internal space. The vortex booster 15 and the tissue cage 16 are detachably fixed in the internal space of the porous tissue scaffold 14. The tissue cage 16 is disposed below the top porous plate 141 and above the vortex booster 15. That is, the bottom porous plate 142, the vortex booster 15, the tissue cage 16, and the top porous plate 141 of the porous tissue scaffold 14 are arranged sequentially from bottom to top. In this way, supercritical carbon dioxide fluid enters the reactor 10 and impacts the vortex booster 15. The vortex booster 15 guides the supercritical carbon dioxide fluid upward and forms a local recirculation vortex in the tissue cage 16.

[0062] The porous tissue scaffold 14 is connected to the inner wall of the pressure vessel body 13 by a threaded connection. It is a detachable structure, which facilitates the placement of biological tissue and the removal of dECM. After installation, the bottom of the porous tissue scaffold 14 is 5-20mm away from the bottom of the pressure vessel body 13 to allow some space for fluid.

[0063] Preferably, a porous tissue scaffold 14 or multiple porous tissue scaffolds 14 stacked vertically can be provided inside the reactor 10.

[0064] Preferably, the top porous plate 141 is connected and fixed to the circumferential sidewall of the bottom porous plate 142 by threads, which facilitates disassembly by the operator. Furthermore, the porous tissue scaffold 14 forms a cage-like structure, which, due to its cage-like structure, prevents dECM from being carried out of the reactor 10 by the fluid.

[0065] The top porous plate 141 and the bottom porous plate 142 are respectively arranged with a plurality of holes in an array, preferably to optimize the flow field distribution, the hole diameter of the holes on the bottom porous plate 142 is larger than that of the holes on the top porous plate 141. The hole diameter of the bottom porous plate 142 is designed to be larger to reduce the resistance when the fluid enters. The hole diameter of the top porous plate 141 is designed to be smaller to generate a certain back pressure on the upward fluid to promote the backflow effect of the fluid in the tissue area. The hole diameter of the bottom porous plate 142 ranges from 6 to 10 mm, and the hole diameter of the top porous plate 141 ranges from 2 to 5 mm.

[0066] The porous tissue scaffold 14 is a single-layer or multi-layer structure stacked together. Preferably, the single-layer height of the porous tissue scaffold 14 is 70-80 mm, and the diameter is 150-155 mm.

[0067] The vortex promoter 15 is a key component to achieve efficient mass transfer and replace mechanical stirring, which includes an impact surface 151, a leg 152 and a support 153. Preferably, the impact surface 151 is a crescent-shaped arc structure. The concave surface of the impact surface 151 faces the top porous plate 141, and the convex surface faces the bottom porous plate 142, so that the tissue cage 16 is above the concave surface area of the impact surface 151.

[0068] The impact surface 151 is arranged above the fluid inlet 131, and the impact surface 151 is fixed in the center of the support 153 through the leg 152, and the vortex promoter 15 is detachably fixed to the side wall of the bottom porous plate 142 through the support 153. Preferably, the vortex promoter 15 has four legs 152, and the impact surface 151 is located in the center of the vortex promoter 15 and is fixed to the support 153 through the four columnar legs 152. The support 153 is annular, and the vortex promoter 15 is installed above the bottom porous plate 142 by a threaded structure, which is convenient for the operator to disassemble. Preferably, the height of the vortex promoter 15 is 45-50 mm, the diameter is 140-145 mm, and the distance from the bottom porous plate 142 is 25-35 mm.

[0069] The tissue cage 16 is a cylindrical structure for containing the biological tissue to be treated, and the upper and lower surfaces and the peripheral surface thereof are arranged with a plurality of holes in an array. A plurality of mounting lugs 161 are arranged at equal intervals on the peripheral surface of the tissue cage 16, and a connecting sleeve 162 corresponding to the mounting lug 161 is arranged on the lower surface of the top porous plate 141. The tissue cage 16 is detachably fixed to the top porous plate 141 through the mounting lug 161 and the connecting sleeve 162.

[0070] Preferably, three inner-threaded connecting sleeves 162 are arranged on the top perforated plate 141, while three mounting lugs 161 corresponding to the positions of the connecting sleeves 162 are arranged on the tissue cage 16, and the mounting lugs 161 and the connecting sleeves 162 can be fixed by fasteners to achieve detachable and high-strength connection between them. Optionally, the fasteners are screws, which pass through the mounting lugs 161 and are screwed into the connecting sleeves 162 to achieve the connection.

[0071] Further, the cage cover of the upper half of the tissue cage 16 is also fixed with the cage body through a threaded structure, which facilitates opening to place the biological tissue to be treated. Preferably, the diameter of the tissue cage 16 is 40-70 mm, and the height is 20-30 mm. The biological tissue to be treated placed in the tissue cage 16 is a tissue strip with a length of 2-3 cm, a width of 1-2 cm, and a thickness of 1-2 cm.

[0072] As shown in Figure 6 (a) is a velocity cloud chart of the scCO2 fluid inside the kettle body, (b) is a velocity vector chart of the scCO2 inside the kettle body, (c) is a streamline chart of the scCO2 fluid inside the kettle body, and (d) is a three-dimensional streamline chart of the scCO2 fluid inside the kettle body.

[0073] When the scCO2 fluid enters the reaction kettle 10 from the fluid inlet 131 at a high flow rate, it first passes through the bottom perforated plate 142 with a larger pore size. Part of the fluid flows out along the top perforated plate 141, but most of the fluid continues to flow downward due to the back pressure formed by the smaller pore size of the top perforated plate 141, forming a stable and continuous macroscopic vortex in the space between the top perforated plate 141 and the vortex inducer 15, which repeatedly and uniformly scours the tissue placed in the tissue cage 16 in the concave area of the vortex inducer 15.

[0074] As shown in Figure 6 (b)-(d), the fluid forms an obvious recirculation path around the tissue, achieving repeated and multi-angle scouring of the tissue. As shown in Figure 7 the top view, the fluid flow rate at the top perforated plate 141 above the vortex inducer is almost 0, further demonstrating the formation of a circulating flow field around the tissue. This design does not require any mechanical stirring components, but relies on fluid dynamics optimization to achieve optimal mass transfer and efficient mixing, while avoiding the high shear damage and equipment complexity that may be caused by mechanical stirring. Finally, the fluid flows out of the reaction kettle 10 through the top perforated plate 141 and the fluid outlet 132.

[0075] To illustrate the impact of the aperture size of the top perforated plate 141 on the scheme of this embodiment, a comparative example is provided. In the comparative example, the top perforated plate 141 is modified by increasing the aperture size, making it consistent with the aperture size of the bottom perforated plate 142. Under the condition that other parameters remain unchanged, this model is simulated, and the simulation results are as follows. Figure 8 As shown. By Figure 8 As can be seen, whether viewed from two-dimensional or three-dimensional perspectives, this model does not form a clear recirculating flow field, and the flow fields cannot be cross-distributed, with many areas where no fluid passes through. This is precisely because the pore size of the top porous plate is relatively large, failing to create a significant back pressure on the fluid. Consequently, the fluid flows directly out of the reactor through the top porous plate 141 from the area of ​​least resistance, thus failing to achieve the ideal effect of repeated flushing of the tissue by the fluid. This highlights the importance of the porous tissue scaffold with a difference in pore size between the upper and lower plates in this invention.

[0076] Example 2

[0077] This embodiment proposes a decellularization reaction system, specifically a complete system for tissue decellularization based on the self-generated eddy current effect of supercritical carbon dioxide fluid, capable of internal and external circulation, such as... Figure 9 As shown. The system mainly includes the reaction vessel 10, carbon dioxide storage tank 20, high-pressure pump 30, heat exchanger 40, and separation tank 50 for fluid separation as described in Embodiment 1 above.

[0078] The outlet of the carbon dioxide storage tank 20 is connected to the fluid inlet 131 of the reactor 10 via a pipeline that passes through the high-pressure pump 30 and the heat exchanger 40 in sequence. The fluid outlet 132 of the reactor 10 is connected to the inlet of the carbon dioxide storage tank 20 via a circulation pipeline that connects to the separation tank 50.

[0079] Since the separator 50 and the circulation pipeline are connected downstream of the reactor 10, a closed-loop external circulation system is formed.

[0080] The overall process flow of the system is as follows:

[0081] CO2 is drawn from the carbon dioxide storage tank 20 through a pipeline, pressurized to supercritical pressure by the high-pressure pump 30, and the pressurized high-density CO2 flows through the heat exchanger 40 and is heated to the supercritical temperature to form scCO2 fluid. The scCO2 fluid enters the reactor 10 to decellularize the biological tissue placed inside the reactor.

[0082] After the decellularization process is completed in the reaction kettle 10, the reacted scCO2 fluid and the dissolved substances (cell components) in the tissue flow out of the fluid outlet 132 of the reaction kettle 10 into the separation tank 50. In the separation tank 50, the solubility of CO2 is reduced by cooling or decompression, so that CO2 and impurities are separated. The separated gaseous CO2 flows out of the separation tank 50, returns to the inlet end of the high-pressure pump 30 through the circulation pipeline, and is re-pressurized and heated to a supercritical state by the high-pressure pump 30 and the heat exchanger 40, and then sent to the inlet of the reaction kettle 10 to realize continuous circulation and utilization of the fluid.

[0083] Thus, the external circulation and reuse of CO2 are realized. Therefore, the system constitutes a closed loop circulation process, realizing green, low-cost and scalable circulation use of scCO2.

[0084] Further, in order to realize the combined treatment of physical and chemical methods, or to explore the influence of different process conditions on the decellularization process, the system is also provided with a cosolvent storage tank 60, and the outlet of the cosolvent storage tank 60 is connected with the cosolvent adding inlet of the reaction kettle 10 through a pipeline. The cosolvent can be a gas material such as ethanol, and optionally, a high-pressure pump is further arranged between the cosolvent storage tank 60 and the reaction kettle 10, and the cosolvent is pressurized by the pump and enters the reaction kettle 10 to realize flexible addition of the cosolvent.

[0085] Further, the heat exchanger 40 in the system which heats CO2 alone can be used not only for decellularization of ordinary biological tissues, but also for exploring the conditions and effects of temperature on scCO2 fluid decellularization. At present, the temperature for decellularization process using scCO2 fluid is controlled at about 37℃, which is close to the physiological temperature. In this embodiment, the solubility of scCO2 fluid is increased by appropriately increasing the fluid temperature, and the decellularization efficiency is further improved without damaging the structure and components of ECM, that is, the effect of temperature on scCO2 fluid decellularization is explored.

[0086] Embodiment 3

[0087] The embodiment provides a method for decellularizing tissue based on fluid dynamics vortex self-generation effect of supercritical carbon dioxide fluid, and adopts the above system. The method comprises the following steps:

[0088] S100, placing the biological tissue to be treated in the tissue cage 16, and sealing the reaction kettle 10.

[0089] Further, after the porous tissue scaffold 14 on which the tissue cage 16 is fixed is loaded into the reaction kettle 10, the sealing and fixing are performed by the clamp 12.

[0090] S200, after adjusting the carbon dioxide to supercritical state, driving the supercritical carbon dioxide fluid into the reaction kettle 10 to carry out the decellularization treatment on the biological tissue to be treated.

[0091] Specifically, it also includes introducing carbon dioxide into the reaction kettle 10, and adjusting its pressure and temperature to supercritical state.

[0092] In step S200, the supercritical carbon dioxide fluid forms a vortex that repeatedly flushes the biological tissue to be treated in the reaction kettle 10 through the vortex inducer 15. Specifically, the supercritical carbon dioxide fluid upwardly impacts the bottom porous plate 142 of the porous tissue scaffold 14, and after passing through the vortex inducer 15, forms a vortex above the concave surface of the vortex inducer 15, which can repeatedly flush the biological tissue to be treated in the tissue cage 16.

[0093] Optionally, during the decellularization treatment in step S200, the reaction kettle 10 can be added with a cosolvent through the cosolvent storage tank 60.

[0094] S300, after completing the decellularization treatment, obtaining the decellularized extracellular matrix of the biological tissue. Specifically, maintaining the preset vortex flushing for a predetermined time, and finally obtaining the decellularized extracellular matrix

[0095] Further, the method further comprises:

[0096] S400, after the decellularization treatment is completed, the supercritical carbon dioxide fluid containing the biological tissue solution flows into the separation tank 50 for separation treatment, and the separated carbon dioxide is recycled for system use.

[0097] Further, the operating temperature range of the supercritical carbon dioxide fluid is 35-50℃, and the pressure range is 15-30MPa; and the biological tissue is xenogeneic or allogeneic tissue, selected from aortic, vascular, skin, bone or nerve tissue, etc.

[0098] The operation method for decellularizing animal myocardial tissue is as follows:

[0099] S1, purchase fresh beef heart from the market and immediately send it to the laboratory, dissect the myocardial slice from the left ventricular wall on the radial axis of the heart, cut it into a slice with a length of about 15mm, a width of about 12mm, and a thickness of about 10mm, and wash it with PBS buffer to remove bloodstains.

[0100] S2, open the clamp 12 of the reaction kettle 10, remove the kettle cover 11, and unscrew the top perforated plate 141. Take out the tissue cage 16, and unscrew its cage cover. Place the pretreated myocardial thin section tissue in the tissue cage 16, and tighten the cage cover by using a screw to pass through the through hole of the mounting lug 161 from below and screw into the internal thread of the connecting sleeve 162 to lock, and fix with the top perforated plate 141. In turn, put back the top perforated plate 141, cover the kettle cover 11, and finally seal and fix the kettle cover 11 with the pressure-bearing kettle body 13 with the clamp 12.

[0101] S3, start the system, open the valve of the carbon dioxide storage tank 20, and pass CO2 into the system through the high-pressure pump 30. After the air is discharged, the system is closed. The pressure in the reaction kettle 10 is increased to 25 MPa, and the temperature of the fluid is controlled at 37℃ through the heat exchanger 40.

[0102] S4, perform decellularization treatment, and control the flow rate of the fluid to be 8000 mL / min by using the high-pressure pump 30. The scCO2 fluid forms a vortex in the decellularization reaction kettle 10, and the myocardial thin section is subjected to dynamic flushing for 1.5 hours.

[0103] S5, if process comparison or better process effect is needed, a small amount of ethanol can be added from the cosolvent storage tank 1-2 through the high-pressure pump according to a certain proportion.

[0104] S6, after the reaction is completed, the system is slowly depressurized until the normal pressure is restored. The decellularization reaction kettle body 1-5 is opened, and the required dECM is taken out.

[0105] S7, the dECM is subjected to histological staining, biochemical analysis and morphological analysis to judge and compare the degree of decellularization. Through characterization, it can be verified that the method of the application can obtain ideal dECM with less cell residues and complete ECM structure, which can be directly applied to subsequent tissue engineering research.

[0106] The method of the embodiment controls the specific flow rate and temperature of the fluid to make the scCO2 fluid enter from the inlet at the bottom of the reaction kettle body, and uses the combined action of the internal arc-shaped vortex inducer and the perforated plate with different pore diameters to generate a vortex for efficient and gentle flushing treatment of the tissue. After the treatment is completed, the fluid can enter the external circulation system for separation and reuse.

[0107] The supercritical carbon dioxide fluid based on the fluid dynamics vortex self-generation effect of the tissue decellularization reaction kettle, system and method of the application, by integrating the static arc vortex inducer and the tissue scaffold with the upper and lower orifice plate aperture difference in the kettle body, using the fluid dynamics principle, the stable and repeated flushing vortex is spontaneously induced around the tissue, and the efficient and mild mass transfer process is realized without mechanical stirring. In addition, the cosolvent adding inlet and the external circulation separation system are combined to realize the efficient, uniform, low-cost and scalable green decellularization process, and a reliable scheme is provided for preparing high-quality dECM.

[0108] The technical features of the above embodiments can be combined in any manner. In order to make the description simple, all possible combinations of the technical features in the above embodiments are not described, however, as long as the combinations of the technical features do not exist contradictory, they should be considered as the scope of the present disclosure.

Claims

1. A reactor for tissue decellularization based on hydrodynamic vortex self- effect of supercritical carbon dioxide fluid, characterized in that, The reaction kettle (10) comprises a kettle cover (11), a clamp (12), and a pressure-bearing kettle body (13) fixed with the kettle cover (11) through the clamp (12); The reaction kettle (10) is provided with a porous tissue support (14) comprising a top porous plate (141) and a bottom porous plate (142) with a circumferential side wall, and the bottom porous plate (142) and the top porous plate (141) form an internal space after being fixed, a vortex inducer (15) and a tissue cage (16) are detachably fixed in the internal space of the porous tissue support (14), and the tissue cage (16) is arranged below the top porous plate (141) and above the vortex inducer (15); The reaction kettle (10) is provided with one porous tissue support (14) or a plurality of porous tissue supports (14) stacked one above another. The supercritical carbon dioxide fluid enters the reaction kettle (10) to impact the vortex inducer (15), the vortex inducer (15) guides the supercritical carbon dioxide fluid upward, and forms a local recirculating vortex in the tissue cage (16).

2. The supercritical carbon dioxide fluid reaction vessel for tissue decellularization according to claim 1, wherein, The top porous plate (141) and the bottom porous plate (142) are respectively arranged with a plurality of holes, and the hole diameter of the holes on the bottom porous plate (142) is greater than the hole diameter of the holes on the top porous plate (141).

3. The supercritical carbon dioxide fluid reaction vessel for tissue decellularization according to claim 1, wherein, The pressure-bearing kettle body (13) is respectively provided with a fluid inlet (131) and a fluid outlet (132), the fluid inlet (131) is arranged at the bottom center of the pressure-bearing kettle body (13), and the fluid outlet (132) is arranged on the upper part of the side wall of the pressure-bearing kettle body (13).

4. The supercritical carbon dioxide fluid reaction vessel for tissue decellularization according to claim 3, wherein, The vortex inducer (15) comprises an impact surface (151), a leg (152), and a support (153), the impact surface (151) is arranged above the fluid inlet (131), the impact surface (151) is fixed at the center of the support (153) through the leg (152), and the vortex inducer (15) is detachably fixed to the side wall of the bottom porous plate (142) through the support (153).

5. The supercritical carbon dioxide fluid reaction vessel for tissue decellularization according to claim 4, wherein, The impact surface (151) is a crescent-shaped arc structure.

6. The supercritical carbon dioxide fluid reaction vessel for tissue decellularization according to claim 1, wherein, The upper and lower surfaces and the peripheral surface of the tissue cage (16) are respectively arranged with a plurality of holes, a plurality of mounting lugs (161) are equidistantly arranged on the upper edge of the peripheral surface of the tissue cage (16), a connecting sleeve (162) corresponding to the mounting lug (161) is arranged on the lower surface of the top porous plate (141), and the tissue cage (16) is detachably fixed to the top porous plate (141) through the mounting lug (161) and the connecting sleeve (162).

7. The supercritical carbon dioxide fluid reaction vessel for tissue decellularization according to claim 1, wherein, The pressure-bearing kettle body (13) is further provided with a cosolvent adding inlet.

8. A system for decellularization of tissue based on hydrodynamic vortex self- effect of supercritical carbon dioxide fluid, characterized in that, The system comprises the reaction kettle (10) of any one of claims 1-7, a carbon dioxide storage tank (20), a high-pressure pump (30), a heat exchanger (40), a separation tank (50), and a cosolvent storage tank (60). The outlet end of the carbon dioxide storage tank (20) is connected with the fluid inlet (131) of the reactor (10) through a pipeline sequentially passing through a high-pressure pump (30) and a heat exchanger (40), and the fluid outlet (132) of the reactor (10) is connected with the inlet end of the carbon dioxide storage tank (20) through a circulating pipeline connecting a separation tank (50). The outlet of the cosolvent storage tank (60) is connected with the cosolvent adding inlet of the reactor (10) through a pipeline.

9. A method of operating a tissue decellularization system using the supercritical carbon dioxide fluid based on the hydrodynamic vortex self-generation effect according to claim 8, characterized in that, The method comprises: placing the biological tissue to be treated in a tissue cage (16) and sealing the reactor (10); adjusting the carbon dioxide to a supercritical state, and then driving the supercritical carbon dioxide fluid into the reactor (10) to perform decellularization treatment on the biological tissue to be treated; obtaining the decellularized extracellular matrix of the biological tissue; wherein the supercritical carbon dioxide fluid forms a vortex in the reactor (10) through a vortex inducer (15) to repeatedly flush the biological tissue to be treated.

10. The method of claim 9, wherein, The method further comprises: adding cosolvent to the reactor (10) through the cosolvent storage tank (60) during the decellularization treatment; and / or, after the decellularization treatment is completed, the supercritical carbon dioxide fluid containing biological tissue solubles flows into the separation tank (50) for separation treatment, and the separated carbon dioxide is recycled for use in the system.

Citation Information

Patent Citations

  • Animal tissue sterile decellularization device

    CN114591832A

  • Acellular dermal tissue prepared by supercritical fluid extraction and application thereof

    CN119156236A

  • Method and devices for preparing biology derivation material

    CN1445003A

  • Cell removal processing of viable tissue for transplantation by supercritical carbon dioxide

    JP2007105081A